Caroline Junqueira
Instituto René Rachou
Fundação Oswaldo Cruz
Caroline Junqueira has not added Biography.
If you are Caroline Junqueira and would like to personalize this page please email our Author Liaison for assistance.
The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease.
Expert reviews in molecular medicine Sep, 2010 | Pubmed ID: 20840799
Trypanosoma cruzi as an effective cancer antigen delivery vector.
Proceedings of the National Academy of Sciences of the United States of America Dec, 2011 | Pubmed ID: 22114198
Trypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccine.
PloS one , 2012 | Pubmed ID: 22567144
Identification and functional analysis of Trypanosoma cruzi genes that encode proteins of the glycosylphosphatidylinositol biosynthetic pathway.
PLoS neglected tropical diseases , 2013 | Pubmed ID: 23951384
Blockade of CTLA-4 promotes the development of effector CD8+ T lymphocytes and the therapeutic effect of vaccination with an attenuated protozoan expressing NY-ESO-1.
Cancer immunology, immunotherapy : CII Mar, 2015 | Pubmed ID: 25403749
Induction of Inhibitory Receptors on T Cells During Plasmodium vivax Malaria Impairs Cytokine Production.
The Journal of infectious diseases Dec, 2015 | Pubmed ID: 26019284
Virus-like Particle Display of the α-Gal Carbohydrate for Vaccination against Infection.
ACS central science Sep, 2017 | Pubmed ID: 28979944
Down Modulation of Host Immune Response by Amino Acid Repeats Present in a Ribosomal Antigen.
Frontiers in microbiology , 2017 | Pubmed ID: 29176965
Comparative transcriptome profiling of virulent and non-virulent Trypanosoma cruzi underlines the role of surface proteins during infection.
PLoS pathogens 12, 2017 | Pubmed ID: 29240831
New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent CL-14 Strain Are Highly Antigenic and Protective against Challenge.
Frontiers in immunology , 2018 | Pubmed ID: 29599776
Cytotoxic CD8 T cells recognize and kill Plasmodium vivax-infected reticulocytes.
Nature medicine 09, 2018 | Pubmed ID: 30038217
The immunology of Plasmodium vivax malaria.
Immunological reviews 01, 2020 | Pubmed ID: 31642531
Decidual NK Cells Transfer Granulysin to Selectively Kill Bacteria in Trophoblasts.
Cell 09, 2020 | Pubmed ID: 32822574
Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage.
PLoS pathogens 09, 2020 | Pubmed ID: 32913355
Caspase-8 mediates inflammation and disease in rodent malaria.
Nature communications 09, 2020 | Pubmed ID: 32929083
Author Correction: Caspase-8 mediates inflammation and disease in rodent malaria.
Nature communications Nov, 2020 | Pubmed ID: 33144583
γδ T cells suppress Plasmodium falciparum blood-stage infection by direct killing and phagocytosis.
Nature immunology 03, 2021 | Pubmed ID: 33432229
Improved Performance of ELISA and Immunochromatographic Tests Using a New Chimeric A2-Based Protein for Human Visceral Leishmaniasis Diagnosis.
Journal of immunology research , 2021 | Pubmed ID: 34007852
SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release.
Research square Aug, 2021 | Pubmed ID: 34401873
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation.
Nature 06, 2022 | Pubmed ID: 35385861
Inflammasome activation in infected macrophages drives COVID-19 pathology.
Nature 06, 2022 | Pubmed ID: 35483404
In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved